Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer
Abstract Human epidermal growth factor receptor-2 (HER2)-targeting drugs are increasingly being incorporated into therapeutic paradigms for non-breast cancers, yet studies on HER2 expression in ovarian cancer (OC) are inadequate. Here, we studied the HER2 status and dynamic changes in OC by reviewin...
Main Authors: | Yoo-Na Kim, Yun Soo Chung, Eunhyang Park, Seung Tae Lee, Jung-Yun Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-04-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-57515-y |
Similar Items
-
Epidermal growth factor receptor blockers for the treatment of ovarian cancer
by: Morrison, J, et al.
Published: (2018) -
Immunohistochemical expression of estrogen receptors, progesterone receptors, and human epidermal growth-factor receptor 2/neu in epithelial ovarian tumors
by: Zaineb Y Mohieldin, et al.
Published: (2022-01-01) -
Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
by: Yong Jae Lee, et al.
Published: (2022-05-01) -
Epidermal Growth Factor Receptor Expression in the Corneal Epithelium
by: Joanne L. Peterson, et al.
Published: (2021-09-01) -
Dexmedetomidine-Induced Aortic Contraction Involves Transactivation of the Epidermal Growth Factor Receptor in Rats
by: Soo Hee Lee, et al.
Published: (2022-04-01)